Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Tradition Meets Innovation -­ Greiner Bio-One Celebrates 50 Successful Years

Published: Friday, December 13, 2013
Last Updated: Thursday, December 12, 2013
Bookmark and Share
Company now has over 1,700 employees spread across seven production facilities.

This year marks the 50th anniversary of Greiner Bio-One GmbH. Over the past five decades, the business founded in Nürtingen, Germany, as Greiner Labortechnik has become an international high-tech company, but it has never lost sight of its modest SMB roots.

Combining tradition with innovation has created a globally successful technology partner for the diagnostic, pharmaceutical and biotechnology industries.

Greiner Labortechnik started out in 1963 in Nürtingen, producing the first plastic Petri dishes. A further production facility that opened in Austria in 1974 also initially manufactured Petri dishes.

In the 1980s, Greiner unveiled VACUETTE ­ the first evacuated blood collection system with a plastic safety cap ­ which can maintain a vacuum for at least 18 months.

This extremely important innovation was key in shaping the company’s further development. Another major breakthrough came in 1997 with the world’s first 1536 well microplate.

In 1988, an ultramodern 15,000 square metre injection moulding production facility opened in Frickenhausen, near Nürtingen. The company also invested in a new production site in the United States and, in 2001, Greiner Labortechnik became Greiner Bio-One International AG.

With a global turnover of 364 million euros, Greiner now has over 1,700 employees spread across seven production facilities and 24 subsidiaries in countries such as France, the Netherlands, Belgium, the United Kingdom, Japan, Hungary, the United States, Switzerland, Brazil, Thailand, China and India.

Based in the Austrian town of Kremsmünster, the Preanalytics division supplies hospitals, clinical laboratories, blood donation centres and the diagnostics industry with complete solutions for venous and capillary blood collection.

Innovations include safety products to protect against needlestick injuries and the VACUETTE PREMIUM tubes with a special screw cap that protect health service professionals against infections.

The division’s latest development is the VACUETTE TUBE TOUCH safety holder. When inserting the tube into the holder, a mechanism activates a safety cap to ensure risk-free blood collection.

The Diagnostics division focuses on DNA chip technology. Biochips provide conclusive proof of the specific genetic fingerprints of many different parameters in a single analysis. The CarnoCheck DNA chip, for example, detects traces of various animal species in food products.

A further significant Greiner Bio-One innovation is the PapilloCheck HPV test, which reliably identifies and flags up 24 strains of the human papillomavirus (HPV). This has taken Greiner Bio-One a big step forward in the early detection of a virus that is the main cause of cervical cancer.

Headed by managing director Heinz Schmid, the German headquarters of the BioScience division in Frickenhausen control all research and development activities in the Cell Culture, High-Throughput Screening and OEM product sectors for markets throughout the world.

Schmid, who started his career as a trainee at the company, sees the anniversary as more than simply an excuse for nostalgia. “I share my staff’s great pride when I see the trust placed in Greiner Bio-One products by scientists and doctors working in areas such as cancer research, virus diagnostics and vaccine production the world over. We are committed to always delivering optimum solutions with our innovations,” he says.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More than 4,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Big Plans and 40 Years of Experience
Rudi Vollmer becomes new Technical Managing Director of Greiner Bio-One GmbH, responsible for production and technology.
Tuesday, June 30, 2015
Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
Drug Candidates Reduce Abnormal Protein Production
New drug candidates improve cell ability to catch miss-folded proteins that could cause deadly diseases.
Supercomputing and Drug Discovery
New biotech company uses supercomputer simulations to speed up drug discovery and biotech molecule development.
Preventing Breast Cancer with Hops
Study of hops extract suggests prevention of breast cancer through chemical pathway activation.
Treatment Advancement for Gaucher and Parkinson's Diseases
NIH scientists identify molecule that may act as a possible treatment of neurological diseases.
Biomunex Confirms Optimal Properties and Activity of BiXAb® Antibodies
Biomunex‘s Plug-and-Play bispecific antibodies demonstrated excellent in vitro properties and in vivo activity positively differentiating their BiXAb platform from competing formats.
Liquid Biopsy Predicts Colon Cancer Recurrence
Scientists have used a genetic test that spots bits of cancer-related DNA circulating in the blood to accurately predict the likelihood of the disease’s return in some — but not all — of a small group of patients with early-stage colon cancer.
New Treatment for Rare Blood Cancers
Drug called midostaurin showed promise in an international clinical trial led by a Stanford physician.
Biomarker for Parkinson's Disease Found in Urine Samples
Protein identified as Parkinson's biomarker sourced from patient's stored frozen urine samples.
Testing for Malaria or Cancer at Home
Chemist develops tech to save lives in rural Africa.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!